American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.
about
Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin forOptimal duration of chemotherapy for advanced non-small cell lung cancerAnti-angiogenic therapy for lung cancerOptimal duration of chemotherapy for advanced non-small cell lung cancerDJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaBEpidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issuesA phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancerLong-term survival after an aggressive surgical resection and chemotherapy for stage IV pulmonary giant cell carcinomaMelatonin as a potential anticarcinogen for non-small-cell lung cancerEGFR mutations as a prognostic and predictive marker in non-small-cell lung cancerThe pemetrexed-containing treatments in the non-small cell lung cancer is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: a meta-analysisTherapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancerWhat future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer?Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic reviewNon-small cell lung cancer: epidemiology, risk factors, treatment, and survivorshipA novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancerPotential Combinational Anti-Cancer Therapy in Non-Small Cell Lung Cancer with Traditional Chinese Medicine Sun-Bai-Pi Extract and CisplatinA network-based method to evaluate quality of reproducibility of differential expression in cancer genomics studiesCeritinib: A primer for pharmacists.A Prospective Phase I/II Study: Combination Chemotherapy with Docetaxel and Pemetrexed as Second-Line Treatment in Patients with Stage IIIB/IV Non-Small Cell Lung CancerMitomycin C in the treatment of gastrointestinal tumours: recent data and perspectives.Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel.Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity.First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II studyPemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients.Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer.Phase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer[A meta analysis of doublets versus single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer].Pemetrexed plus platinum or gemcitabine plus platinum for advanced non-small cell lung cancer: final survival analysis from a multicentre randomized phase II trial in the East Asia region and a meta-analysis.Is there still a role for mitomycin-based combination chemotherapy in treating patients with nonsmall cell lung cancer? A single institution experience.A phase II study of amrubicin as a third-line or fourth-line chemotherapy for patients with non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901Doublets versus single-agent therapy as first-line therapy for elderly patients with advanced non-small cell lung cancer? A systematic review of randomised controlled trials.Comparison between cisplatin plus vinorelbine and cisplatin plus docetaxel in the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials.Comparison of nedaplatin-based versus cisplatin-based chemotherapy for advanced non-small cell lung cancer among East Asian populations: A meta-analysis.A phase II, open-label trial of bortezomib (VELCADE(®)) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer.Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling.American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.Has the practice of radiation oncology for locally advanced and metastatic non-small-cell lung cancer changed in Canada?Comparison of the epidermal growth factor receptor protein expression between primary non-small cell lung cancer and paired lymph node metastases: implications for targeted nuclide radiotherapy.
P2860
Q21261297-91ADFBEA-C21C-4016-A290-08521D15A931Q24200970-4891CC1A-E278-4643-97A8-BED271C2C757Q24240857-954E3376-E073-48C9-8150-66EE1476468BQ24242409-AA905621-3CF3-44FC-92E6-431E7D875096Q24307823-601909E5-AC17-4337-8002-E918B3788882Q24653036-57A1142E-E481-4EF4-BA29-924098E4D3A8Q24796746-A3AC4C88-DD79-47CC-8DDA-E07971E55890Q24815977-FB275828-2FCD-438D-BF08-52EE42353EE5Q26751220-C540A112-3447-45B3-AC00-7AC3FD401795Q26852507-242A9BAB-C809-409C-BF02-64B107A80CCFQ26999925-599AAF25-346D-4800-8FDE-DF35F210B452Q27004357-424712BF-2C3F-4A60-87FF-BE205B1CC09DQ27012886-753738AD-0A74-4650-B4EE-3CC3A76F52ABQ27025724-ED7AE503-71A8-4385-8598-2AF0BF85ED95Q28278682-A12DFC42-C66A-4DB3-A750-E53383A964C8Q28475503-9194123A-D4CE-45A9-8F0D-7F5EB1EC76C2Q28552029-1058A126-86F2-48E0-8DC3-C328872D1A24Q28602622-1DC8B57D-1328-4DFD-A397-90BF34665322Q30244613-DE810BF4-0F5F-42A6-A26F-3DA7C05C6881Q30317149-D206203B-C263-4F86-9B5A-D4BBAAF07B93Q31156315-6BDCD454-868D-4FF2-8D51-E5DF27F95F9DQ33286793-406B8A5E-AE98-425A-AF28-9343EEF5097CQ33374962-239F1F39-EE0D-4205-8A38-2512132F5DB0Q33375704-698C1CBE-A15D-499F-A3DF-761B2D448D4DQ33378383-F1F3E000-8D8E-4379-9118-42BF467E136DQ33389316-23480CA0-896F-4B59-B804-0CD4393FD986Q33392253-1C35A6F5-D346-4BBB-8E49-CB19517A50DCQ33401530-E09AA422-465F-49DA-8591-402202D4AA21Q33401712-A427E4B6-E0CD-4E7D-B7CF-5979D6689F05Q33402765-39255E3B-728D-42D5-845C-E6686B5BEA2EQ33403648-65689DF6-811E-4C58-BA71-9B8DB7588FE2Q33406103-DBBC090C-5C68-49DA-BB74-72C3EC279B2DQ33411167-D763E0B1-5442-4111-9A2D-987A09487076Q33414080-6BDCA6DC-BF6E-44EA-93E4-20C9159B2203Q33422985-D491E484-2AFC-498F-B220-1BEE9CEDEC63Q33430874-FF603AB6-9C8D-421A-B493-8BBEDC3BB289Q33499899-7D1C055A-F39B-4207-AAD6-933AAB4F4B76Q33586120-D678BC5B-834A-4472-85F7-03EA4606C8CAQ33680350-9D6F7601-2D1C-4A47-AE12-7CF9EB400797Q33698339-A586B378-8453-4C43-9306-1B9960AE6B11
P2860
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
American Society of Clinical O ...... cancer guideline: update 2003.
@ast
American Society of Clinical O ...... cancer guideline: update 2003.
@en
type
label
American Society of Clinical O ...... cancer guideline: update 2003.
@ast
American Society of Clinical O ...... cancer guideline: update 2003.
@en
prefLabel
American Society of Clinical O ...... cancer guideline: update 2003.
@ast
American Society of Clinical O ...... cancer guideline: update 2003.
@en
P2093
P356
P1476
American Society of Clinical O ...... cancer guideline: update 2003.
@en
P2093
Andrew T Turrisi
Christopher G Azzoli
David G Pfister
David H Johnson
Diane Stover
John R Strawn
Mark R Somerfield
Sherman Baker
Thomas J Smith
P304
P356
10.1200/JCO.2004.09.053
P407
P577
2003-12-22T00:00:00Z